Drug intelligence / Profile preview

Ferronyl

Development stage
Unknown
Lead developer
Ashland
Administration
Oral
01

Overview

Ferronyl is a trademarked form of carbonyl iron used in dietary iron supplements, valued for its high bioavailability, good tolerability, and low toxicity profile compared to other iron forms. It provides elemental iron (typically 9-54 mg per serving depending on the product) in timed-release tablet formulations that release over 6 hours to minimize gastrointestinal side effects. Iron from Ferronyl supports essential physiological functions including hemoglobin and myoglobin production for oxygen transport, cytochrome-mediated electron transport, and enzyme reactions critical for energy production, hormone synthesis, and neurological health. It is primarily indicated to treat or prevent iron deficiency, anemia, and low iron levels, particularly in contexts like pregnancy or general mineral deficiency, which is the world's most common nutrient shortfall leading to fatigue, poor concentration, and weakened immunity.[1][2][3][5][8]

Brand names
Ferronyl
Other names
Ferronyl iron carbonyliron carbonyl

Beyond the preview

Go deeper on Ferronyl.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ferronyl.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call